Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Bloom

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Alimentary Pharmacology & Therapeutics|May 29, 2019
Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005-2013Mustafa Shawihdi, Susanna Dodd, Constantinos Kallis, et al.
Health Technology Assessment (Winchester, England)|July 6, 2021
Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic reviewSteve Halligan, Darren Boone, Lucinda Archer, et al.
Journal of Crohn'S & Colitis|September 14, 2023
Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: secondary analysis of a nationwide electronic surveyGerum G Gebeyehu, Frederick Taylor, Liz Dobson, et al.
World Journal of Gastroenterology|November 17, 2012
Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-lineSimona Di Caro, Lucia Fini, Yayha Daoud, et al.
Therapeutic Advances in Gastroenterology|June 4, 2026
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomesKeith Bodger, Cheryl Booker, Frederick Taylor, et al.
European Journal of Radiology|September 20, 2011
Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity indexMichael J Steward, Shonit Punwani, Ian Proctor, et al.
European Radiology|September 13, 2013
Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectinJesica C Makanyanga, Doug Pendsé, Nikolaos Dikaios, et al.
Inflammatory Bowel Diseases|March 15, 2018
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative ColitisPeter M Irving, Tariq Iqbal, Chuka Nwokolo, et al.
Lancet (London, England)|March 1, 2006
Defective acute inflammation in Crohn's disease: a clinical investigationDaniel J B Marks, Marcus W N Harbord, Raymond MacAllister, et al.
Therapeutic Advances in Gastroenterology|July 30, 2025
Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn's disease: results from the BISCUITS studyFrederick Taylor, Giorgio Bartalucci, Catherine Gleave, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|May 29, 2019
Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005-2013Mustafa Shawihdi, Susanna Dodd, Constantinos Kallis, et al.
Health Technology Assessment (Winchester, England)|July 6, 2021
Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic reviewSteve Halligan, Darren Boone, Lucinda Archer, et al.
Journal of Crohn'S & Colitis|September 14, 2023
Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: secondary analysis of a nationwide electronic surveyGerum G Gebeyehu, Frederick Taylor, Liz Dobson, et al.
World Journal of Gastroenterology|November 17, 2012
Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-lineSimona Di Caro, Lucia Fini, Yayha Daoud, et al.
Therapeutic Advances in Gastroenterology|June 4, 2026
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomesKeith Bodger, Cheryl Booker, Frederick Taylor, et al.
European Journal of Radiology|September 20, 2011
Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity indexMichael J Steward, Shonit Punwani, Ian Proctor, et al.
European Radiology|September 13, 2013
Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectinJesica C Makanyanga, Doug Pendsé, Nikolaos Dikaios, et al.
Inflammatory Bowel Diseases|March 15, 2018
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative ColitisPeter M Irving, Tariq Iqbal, Chuka Nwokolo, et al.
Lancet (London, England)|March 1, 2006
Defective acute inflammation in Crohn's disease: a clinical investigationDaniel J B Marks, Marcus W N Harbord, Raymond MacAllister, et al.
Therapeutic Advances in Gastroenterology|July 30, 2025
Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn's disease: results from the BISCUITS studyFrederick Taylor, Giorgio Bartalucci, Catherine Gleave, et al.
Pageof 5